Zhao Jun-zhao, Ge Hong-shan, Ye Bi-lü, Huang Xue-feng, Zhou Hong-wei, Chi Hai-hong, Yang Hai-yan
Reproductive Medicine Center, First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, China.
Zhonghua Fu Chan Ke Za Zhi. 2006 Mar;41(3):173-6.
To evaluate the efficacy of in vitro maturation (IVM) and fertilization of unstimulated immature oocytes for the treatment of infertile women.
Fifty-four cycles of IVM were carried out in 40 patients including 26 women with infertility due to polycystic ovary syndrome (PCOS), and 14 patients with history of assisted reproductive technology (ART) failure. Transvaginal ultrasound-guided oocyte collection was performed during menstrual cycle days 9 - 12 without pretreatment of gonadotropins. After 24 - 48 hours of culture, the metaphase II stage oocytes were inseminated by intracytoplasmic sperm injection (ICSI). Embryo transfer was performed 2 or 3 days after ICSI. Laser assisted hatching was done before embryo transfer.
Seven cycles were cancelled and the cancel rate was 13% (7/54). A total of 857 immature oocytes were obtained with the mean numbers of 18.2 per cycle, and 632 oocytes developed at MII stage (73.7%, 632/857). A total of 476 oocytes were fertilized by ICSI (75.3%, 476/632), with a cleavage rate of 91.2% (434/476). Embryo transfer was performed in 47 cycles and the mean number of embryos transferred were 4.3 per cycle (range: 2 - 6). The mean endometrial thickness on the day of embryo transfer was 8.9 mm. Nineteen clinical pregnancies were obtained, giving a pregnancy rate of 35% (19/54) per start cycle and 40% (19/47) per transfer cycle.
IVM of unstimulated immature oocytes for the treatment of women with various causes of infertility especially due to PCOS is an effective alternative method. The clinical pregnancy rate of 40% (19/47) is similar to that by conventional in vitro fertilization treatment in our unit.
评估未刺激的未成熟卵母细胞体外成熟(IVM)及受精用于治疗不孕女性的疗效。
对40例患者进行了54个周期的IVM,其中包括26例因多囊卵巢综合征(PCOS)导致不孕的女性,以及14例有辅助生殖技术(ART)失败史的患者。在月经周期第9 - 12天,在未使用促性腺激素预处理的情况下,经阴道超声引导下采集卵母细胞。培养24 - 48小时后,对处于中期II期的卵母细胞进行卵胞浆内单精子注射(ICSI)受精。在ICSI后2或3天进行胚胎移植。在胚胎移植前进行激光辅助孵化。
7个周期被取消,取消率为13%(7/54)。共获得857个未成熟卵母细胞,平均每个周期18.2个,632个卵母细胞发育至MII期(73.7%,632/857)。共476个卵母细胞通过ICSI受精(75.3%,476/632),卵裂率为91.2%(434/476)。47个周期进行了胚胎移植,平均每个周期移植胚胎数为4.3个(范围:2 - 6个)。胚胎移植当天子宫内膜平均厚度为8.9 mm。获得19例临床妊娠,起始周期妊娠率为35%(19/54),移植周期妊娠率为40%(19/47)。
未刺激的未成熟卵母细胞IVM用于治疗各种原因导致的不孕女性,尤其是PCOS患者,是一种有效的替代方法。40%(19/47)的临床妊娠率与我们单位传统体外受精治疗的妊娠率相似。